Xavier Garcia-Del-Muro

7PUBLICATIONS
136CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 17, 2025
Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial.

Xavier Garcia-Del-Muro, Begoña P Valderrama, Ana Medina-Colmenero

|Sep 30, 2023
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.

Jakob Lauritsen, Nicolas Sauvé, Alexey Tryakin

|Oct 14, 2022
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression.

Cora N Sternberg, Daniel P Petrylak, Joaquim Bellmunt

|Apr 08, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.

Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah

|Apr 06, 2021
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.

Silke Gillessen, Nicolas Sauvé, Laurence Collette

|Jan 22, 2021
Sarcoma classification by DNA methylation profiling.

Christian Koelsche, Daniel Schrimpf, Damian Stichel

Pageof 2

Frequent Collaborators

2 joint publications

Andrea Necchi

2 joint publications

Christian Fankhauser

2 joint publications

Robert Huddart

2 joint publications

Gedske Daugaard